Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An analysis of nearly 8,000 heart transplants found that whether or not the donor had hepatitis C, 90% of recipients survived one year.
One year after such transplantations, the outcomes are similar to those who receive hearts not infected with hepatitis C.
A meta-analysis has helped clear up conflicting previous evidence regarding this association.
February is American Heart Month. When was the last time you had your cholesterol levels checked?
People without hep C received kidney, liver or heart transplants from HCV-positive donors and then were treated for the virus.
A look at the relationship between hepatitis C and cardiovascular disease.
A recent meta-analysis found that the addition of hepatitis C raises a cardiovascular disease risk already elevated by HIV.
A look at a common heart problem in observance of World Heart Day on Sep 29
Fans finally have answers more than two months after the pop idol was found dead in his home on Christmas Day at age 53.
A California man suffering from heart failure, liver failure and hepatitis C has been given a second chance at life.
Today’s highlights from the 2016 Liver Meeting look at hepatitis C treatment, the heart, and insulin resistance.
Lowering blood pressure also reduces heart attack risk.
People with hep C virus (HCV) have higher rates of cardiovascular disease (CVD) than HCV-negative individuals with similar risk factors.
Patients at the Raleigh Heart Clinic may have been exposed to blood-borne illnesses through injectable medications they received there.
Getting access to the new hep C drugs remains an ongoing barrier for too many people, but the drugs keep getting better.
HCV regimens containing Gilead Sciences’ Sovaldi (sofosbuvir) may in rare cases cause a severe slowing of the heart.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.